Life Seal Vascular Appoints Dr. Matt Thompson as Chief Executive Officer

March 10, 2025—Life Seal Vascular Inc, announced the appointment of Matt Thompson, MD, as Chief Executive Officer (CEO).

The appointment positions the company to accelerate the development and commercialization of its vascular technologies, stated Life Seal Vascular.

According to the company, Dr. Thompson is a globally recognized vascular surgeon and medical device executive with extensive experience in implantable Class III medical devices. From 2002 to 2016, he served as a vascular surgeon at St. George’s Hospital in London, United Kingdom.

The press release noted that in 2016, Dr. Thompson transitioned to the medical device industry as Chief Medical Officer at Endologix and was appointed CEO in 2021. In January 2025, he stepped down as President and CEO of Endologix and took on a new role with the company as Executive Vice President and Chief Medical Officer.

Dr. Thompson will continue to contribute to Endologix as Chief Medical Officer, advised Life Seal Vascular.

“I am honored to join Life Seal Vascular at this pivotal stage,” commented Dr. Thompson in the company’s press release. “The company is developing breakthrough endovascular solutions that address critical unmet clinical needs, particularly in the prevention of type II endoleaks following endovascular aneurysm repair. I look forward to working with the team to bring these innovations to patients and clinicians worldwide.”

Robert Mitchell, Executive Chairman of Life Seal Vascular, added, “We are thrilled to welcome Dr. Thompson as our CEO. His unique combination of clinical expertise and executive leadership in the vascular medical device industry makes him the ideal leader to drive our next phase of growth. His prior service on our Board has provided him with deep insight into our company’s mission and we are excited for his leadership as we advance our technologies into clinical use.”